NCT06036823View on ClinicalTrials.gov

5 Versus 10 Units of Insulin in Hyperkalemia Management

PHASE4RecruitingINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

December 31, 2024

Conditions
HyperkalemiaPotassium ImbalanceElectrolyte ImbalanceElectrolyte Disturbance
Interventions
DRUG

Insulin regular

Intravenous insulin

DRUG

Dextrose 50

to be given to both arms

DRUG

salbutamol

to be given to all patients

Trial Locations (1)

123

RECRUITING

Sultan Qaboos University hospital, Seeb

All Listed Sponsors
collaborator

Sultan Qaboos University

OTHER

lead

Oman Medical Speciality Board

OTHER_GOV